Click on headlines below to download research
Management’s strategy of generating more profit from its crops by selling processed onions and potatoes, supported by higher farm gate milk prices…
CLIQ Digital’s FY17 results were slightly short of guidance and consensus estimates, yet still delivered 23% increase in net income underpinned by…
FinLab continues to expand its portfolio of fintech investments (currently nine holdings), putting special emphasis on opportunities in the blockchain…
Heliad Equity Partners (Heliad) posted strong results for FY17, with profit before tax of €39.6m compared with a loss of €22.2m in FY16. This…
While longstanding brand and financial strengths hold true, Borussia Dortmund (BVB) is currently bedevilled by uncertainties. Some, such as the absence…
Nanogate is taking innovative surfaces to the next level, offering intelligent surfaces with embedded electronic circuits where the surface itself interacts…
Together with its Q417 results announced last week, 4SC also reported progress with its R&D activities. All three lead assets – resminostat,…
The turnaround in business levels in life insurance after the weak first half improves visibility, although the overall environment remains challenging.…
Helma’s FY17 results exhibit moderate growth (sales up 1.4% y-o-y) due to constrained capacity in the German construction market. However, demand…
Medigene has started its TCR Phase I/II clinical trial, making it one of the few clinical TCR companies globally. Combined with the completed enrolment…
JDC Group has been successful in implementing its fintech strategy so far and continues to acquire new insurance portfolios, as illustrated by the recent…
The announcement that Cargill has officially started producing EverSweet brings commercial reality to Evolva’s stevia product, after years of R&D.…
Mensch und Maschine’s FY17 results confirmed that its Software business continues to generate strong growth and margins. The VAR business managed…
artec has won three prestigious new contracts in recent months that provide a strong endorsement of the company’s new platform. The wins come in…
The recent selling pressure on publity’s shares (price down 48% ytd) was accompanied by negative newsflow in January, including a profit warning…
While arguably riding its luck of late, Borussia Dortmund (BVB) is well-placed to exploit immediate Bundesliga and Europa League opportunities. However,…
MPC Capital met its 2017 financial performance targets. The share price has suffered in the recent shake-out. P/NAV has slipped to a relatively undemanding…
FY17 was a year of strong growth for DATAGROUP, with revenues rising by 28% and EBITDA surging 42%. The EBITDA margin rose by 120bp to a record 12.1%.…
MagForce has received IDE approval to start its first pivotal clinical trial evaluating NanoTherm focal ablation therapy for prostate cancer in the US.…
aap Implantate’s preliminary FY17 results show an encouraging 20% y-o-y growth in trauma revenues, with the strongest performance coming from the…
HBM Healthcare Investments (HBMN) reported profits of CHF72m for the third quarter of its financial year, buoyed by the takeover of long-term holding Advanced…
Deutsche Beteiligungs (DBAG) reported a 2.7% NAV return for the three months ended 31 December 2017, with the period characterised by a high level of transaction…
Edel’s results to September 2017 were comfortably ahead of earlier guidance, revised post year-end. Revenues were boosted by good demand at Optimal…
Over the past several months 4SC has reported progress with both its clinical-stage assets – resminostat and 4SC-202. The pivotal trial with resminostat…
Beta’s FY17 results were towards to the middle of its guidance; strong licence sales in DCI and management’s efficiency drive resulted in a…